Compile Data Set for Download or QSAR
Report error Found 91 Enz. Inhib. hit(s) with all data for entry = 8458
TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249789(US9447087, 17 | US9447087, 57)
Affinity DataIC50: 595nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249831(US9447087, 67)
Affinity DataIC50: 651nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249808(US9447087, 41)
Affinity DataIC50: 749nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249793(US9447087, 22)
Affinity DataIC50: 1.06E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249830(US9447087, 66)
Affinity DataIC50: 1.16E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249832(US9447087, 68 | US9447087, 71)
Affinity DataIC50: 1.46E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249789(US9447087, 17 | US9447087, 57)
Affinity DataIC50: 2.66E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249792(US9447087, 21)
Affinity DataIC50: 2.66E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249833(US9447087, 69)
Affinity DataIC50: 2.91E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249834(US9447087, 70)
Affinity DataIC50: 2.91E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249838(US9447087, 75)
Affinity DataIC50: 2.91E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249849(US9447087, 86)
Affinity DataIC50: 3.26E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249839(US9447087, 76)
Affinity DataIC50: 3.26E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249844(US9447087, 81)
Affinity DataIC50: 3.26E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249855(US9447087, 93)
Affinity DataIC50: 3.26E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249862(US9447087, 100)
Affinity DataIC50: 3.66E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249843(US9447087, 80)
Affinity DataIC50: 3.66E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249848(US9447087, 85)
Affinity DataIC50: 4.11E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249842(US9447087, 79)
Affinity DataIC50: 4.11E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249779(US9447087, 4)
Affinity DataIC50: 4.21E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249841(US9447087, 78)
Affinity DataIC50: 4.61E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249868(US9447087, 108)
Affinity DataIC50: 5.17E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249864(US9447087, 102)
Affinity DataIC50: 5.17E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249782(US9447087, 7)
Affinity DataIC50: 5.17E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249840(US9447087, 77)
Affinity DataIC50: 5.17E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249847(US9447087, 84)
Affinity DataIC50: 5.80E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249796(US9447087, 26)
Affinity DataIC50: 5.95E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249854(US9447087, 92)
Affinity DataIC50: 6.51E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249856(US9447087, 94)
Affinity DataIC50: 6.51E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249783(US9447087, 8)
Affinity DataIC50: 6.68E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249791(US9447087, 20)
Affinity DataIC50: 6.68E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249824(US9447087, 59)
Affinity DataIC50: 6.68E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249823(US9447087, 58)
Affinity DataIC50: 6.68E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM2764(US9447087, 24 | 2-(benzo[d]oxazol-2-ylamino)-4',5'...)
Affinity DataIC50: 6.68E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249797(US9447087, 27)
Affinity DataIC50: 7.49E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249859(US9447087, 97 | US9447087, 112)
Affinity DataIC50: 8.19E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249803(US9447087, 36)
Affinity DataIC50: 8.41E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249860(US9447087, 98)
Affinity DataIC50: 9.19E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249859(US9447087, 97 | US9447087, 112)
Affinity DataIC50: 9.19E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249851(US9447087, 89)
Affinity DataIC50: 9.19E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249852(US9447087, 90)
Affinity DataIC50: 9.19E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249829(US9447087, 65)
Affinity DataIC50: 9.19E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249788(US9447087, 16)
Affinity DataIC50: 9.43E+3nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249846(US9447087, 83)
Affinity DataIC50: 1.03E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249867(US9447087, 107)
Affinity DataIC50: 1.16E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249787(US9447087, 14)
Affinity DataIC50: 1.19E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249806(US9447087, 39)
Affinity DataIC50: 1.22E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249825(US9447087, 60)
Affinity DataIC50: 1.30E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249785(US9447087, 10)
Affinity DataIC50: 1.33E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

TargetGalactokinase(Human)
University of Utah

US Patent
LigandPNGBDBM249836(US9447087, 73)
Affinity DataIC50: 1.46E+4nMAssay Description:Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: